NCT04668352: A trial that was reported late by Restorbio Inc.
This trial has reported, although it was 180 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04668352 |
|---|---|
| Title | A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 15, 2019 |
| Completion date | Dec. 2, 2019 |
| Required reporting date | Dec. 1, 2020, midnight |
| Actual reporting date | May 31, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 180 |